FdaApplication

ANDA 218163

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRISING PHARMA HOLDINGS INC
application_typeANDA
approval_date2024-04-09

Products (2)

ProductActive ingredientStrengthDosage form
RASAGILINE MESYLATERASAGILINE MESYLATEEQ 0.5MG BASETABLET;ORAL
RASAGILINE MESYLATERASAGILINE MESYLATEEQ 1MG BASETABLET;ORAL

2 products